Here are relevant reports on : parcel-delivery-terminals-market
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market, valued at US$15.46 billion in 2025, stood at US$16.46 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of US$22.54 billion by the end of the period. The demand for fill-and-finish services is increasing, contributing to the growth of the injectable drug delivery market in the Middle East & Africa.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) & Region - Global Forecast to 2026
The global animal antibiotics market growth is primed to transition from $4.7 billion in 2021 to $5.6 billion by 2026, showcasing a strong CAGR of 3.6%. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
North America Learning Management System Market by Delivery Mode (Distance Learning, Instructor-led Learning, Blended Learning), Application Area (Corporate Training & Development, Professional Certification & Compliance) - Forecast to 2032
The learning management system market in North America is expected to grow steadily, rising from USD 12.54 billion in 2025 to USD 34.76 billion by 2032, at a CAGR of 15.7%. The key players include Anthology (US), Moodle (Australia), Cornerstone OnDemand (US), D2L Corporation (Canada), Instructure Inc. (US), PowerSchool (US), IBM (US), Infor (US), Adobe (US), Docebo (Canada), Absorb LMS (Canada), BizLibrary (US), iSpring (US), DigitalChalk (US), and Touvti LMS (US).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Forecast to 2030
The Europe pharmaceutical packaging market is projected to reach USD 95.78 billion by 2030 from USD 49.24 billion in 2025, at a CAGR of 14.2% during the forecast period. German pharmaceutical packaging manufacturers are subject to some of the most stringent regulations and quality norms in Europe, as they are compliant with EU GMP, European Medicines Agency (EMA), and EU Falsified Medicines Directive (FMD). These requirements are encouraging continued investment in advanced materials, cleanroom manufacturing, and digitalized packaging technologies. The report profiles key companies, including Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Nolato AB (Sweden), and Smurfit Westrock (Ireland), which are some major players in the Europe pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Claims Management Market by Component (Software, and Services), Delivery Mode (On-Premise, and Cloud Based), Type (Integrated, and Standalone), End User (Healthcare Payers, Providers) - Global Forecast to 2023
The global healthcare claims management market is projected to reach USD 13.93 billion by 2023 from USD 10.77 billion in 2018, at a CAGR of 5.3% during the forecast period. The key factors driving the growth of this market are increasing patient volumes, expanding health insurance market, growing importance of denials management, and declining reimbursement rates. Cerner Corporation (US), McKesson Corporation (US), athenahealth (US), eClinicalWorks (US), Optum, Inc, (US), Conifer Health Solutions (US), and nThrive (US) are the key players in the healthcare claims management solutions market. Other players involved in this market are DST Systems (US), Cognizant Technology Solutions (US), Allscripts Healthcare Solutions, Inc. (US), Context 4 Healthcare (US), Health Solutions Plus (US), GE Healthcare (US), RAM Technologies (US), Quest Diagnostics (US), The SSI Group (US), PLEXIS Healthcare Systems (US), and GeBBS Healthcare Solutions (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Patient Relationship Management Software Market by Delivery (On-premise, Web & Cloud-based), Usage (PC, Laptop, Smartphone), End User (Healthcare Payers, Healthcare Providers), Application (Patient Education, Disease Management) - Global Forecasts to 2019
The global patient relationship management software market is estimated to grow at a high rate from 2014 to 2019. A number of factors such as greater emphasis on delivery of high quality patient care facilities, increasingly affordable computing infrastructure, growing integration of hospitals, data centers, clinics, and pharmacies into single service providing networks, rising awareness about personalized medicine among patients, and global burden of chronic diseases (such as cancer, orthopedic, cardiovascular and infectious diseases) are fuelling the growth of patient relationship management software market. However, reluctance to adopt advanced IT tools among healthcare providers and cost containment measures among healthcare providers has subdued IT budget of end users, which is hampering the growth of this market. Emerging markets such as Middle East, China, India, and Brazil have become attractive destinations for companies engaged in the development and marketing of patient relationship management software products. A number of factors such as growing adoption of information technology services to improve healthcare facilities and increasing market penetration of leading software companies in emerging healthcare markets are offering high growth opportunities for players active in the global patient relationship management software market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Rich Communication Services (RCS) Market by Application (Advertising Campaign, Content Delivery, and Integrated Solutions), End-User (Consumers and Enterprises), Enterprise Size, Enterprise Vertical, and Region - Global Forecast to 2025
The global Rich Communication Services (RCS) market size is expected to grow USD 11.7 billion by 2025, at a CAGR of 17.6% during the forecasting period. Major vendors covered in the RCS market include AT&T (US), Vodafone (Uk), Deutsche Telekom (Germany), Google (US), Verizon (US), Telefonica (Spain), Orange Business (US), China Mobile (China), KDDI (Japan), Slovak Telekom (Slovakia), Telit (UK), SK Telecom (South Korea), Telstra (Australia), LG U+ (South Korea), Celcom (Malaysia), Freedom Mobile (Canada), Rogers (Canada), T-Mobile (US), O2 (UK), Telia Company (Sweden), Magyar Telekom (Hungary), Claro (Brazil), Swisscom (Switzerland), and Reliance Jio (India).
- Published: June 2020
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
